Independence Blue Cross Paid $22.5 Million in False Claims Settlement
Pennsylvania-based insurers face heightened scrutiny for managing Medicare diagnosis code reporting accuracy.
Updated on Sept. 30, 2026 in Healthcare
Live Poll
Should insurance companies face stricter oversight when reporting medical diagnosis data to federal programs?
Independence Blue Cross reached a $22.5 million settlement to resolve allegations that it submitted inaccurate diagnosis codes to the Centers for Medicare & Medicaid Services between 2017 and 2021. The agreement follows a whistleblower lawsuit alleging the company inflated risk adjustment payments by failing to withdraw known diagnosis errors.
Why it matters
The settlement highlights the intense regulatory focus on risk adjustment practices, where insurers must balance aggressive chart review processes with strict compliance obligations to avoid overpayment penalties. Operators in the healthcare space must ensure that revenue integrity programs prioritize the accuracy of data submitted to federal payers.
Independence Blue Cross agreed to a $22.5 million settlement regarding alleged Medicare overpayments from 2017 through 2021. A whistleblower involved in the case will receive $3,825,000 as part of the resolution.
The players
Independence Blue Cross
A major Pennsylvania-based health insurer and regional provider of Medicare Advantage plans.
Centers for Medicare & Medicaid Services
The federal agency responsible for managing Medicare and regulating risk adjustment payments to insurers.
The details
The allegations centered on the company's use of nurse-led chart review programs to identify medical conditions for higher-tier risk adjustment payments. According to the United States, the insurer actively utilized positive review findings to increase revenue while systematically failing to remove inaccurate codes that required repayment to the federal government.
Timeline
The alleged reporting inaccuracies occurred between 2017 and 2021.
The settlement was announced on September 30, 2026.
Market Landscape
This resolution aligns with the Department of Justice's stepped-up enforcement of the False Claims Act within the Medicare Advantage sector. It underscores a shift toward higher scrutiny of how insurers leverage internal chart review data to influence federal risk-adjustment payments.
Healthcare operators should conduct regular audits of their billing and risk-adjustment submissions to ensure internal chart reviews meet federal compliance standards. Consulting with legal counsel regarding the documentation of identified billing errors is critical for mitigating future liability.
The takeaway
Reliance on selective data review to maximize federal payments creates significant compliance risks under the False Claims Act. Operators should prioritize rigorous, transparent record-keeping of all chart review results to defend against potential whistleblower or agency investigations.
Further reading
For more on industry compliance trends, visit the Healthcare section.
More information
To report suspected billing inaccuracies, visit the HHS health fraud reporting portal.
Live Poll
Should insurance companies face stricter oversight when reporting medical diagnosis data to federal programs?
